Synthesis and pharmacological properties of new GABA uptake inhibitors.

Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 4

Abstract

Background: γ-Aminobutanoic acid (GABA) is the principal inhibitory neurotransmitter in the mammalian central nervous system. The identification and subsequent development of the GABA transport inhibitors which enhance the GABA-ergic transmission has shown the important role that GABA transporters play in the control of numerous functions of the nervous system. Compounds which inhibit GABA uptake are used as antiepileptic drugs (tiagabine - a selective GAT1 inhibitor), they are also being investigated for other indications, including treatment of psychosis, general anxiety, sleep disorders, drug addiction or acute and chronic pain. Methods: In this paper, the synthesis of 2-substituted-4-(1,3-dioxoisoindolin-2-ylo)-butanamides and 2-substituted-4-aminobutanoic acids derivatives is described. These compounds were tested in vitro for their ability to inhibit GABA uptake. The inhibitory potency towards murine plasma membrane GABA transporters (mGAT1-4) was performed as [(3)H]GABA uptake assay based on stably transfected HEK cells. Compound 18, which demonstrated the highest affinity for mGAT1-4 (pIC(50) ranged from 4.42 for mGAT1 to 5.07 for mGAT3), was additionally investigated in several behavioral tests in mice. Results: Compound 18 increased the locomotor activity (14-38%) and had anxiolytic-like properties in the four-plate test (ED(50) = 9.3 mg/kg). It did not show analgesic activity in acute pain model, namely the hot plate test, however, it was antinociceptive in the acetic acid-induced writhing test (ED(50) = 15.3 mg/kg) and in the formalin model of tonic pain. In the latter assay, it diminished nocifensive behavior in both phases and in the first (neurogenic) phase of this test the obtained ED(50) value (5.3 mg/kg) was similar to morphine (3.0 mg/kg). Conclusion: Compound 18 exhibited significant anxiolytic-like properties and was antinociceptive in some models of pain in mice. Moreover, it did not impair animals' motor coordination in the chimney test. Some of the described pharmacological activities of compound 18 can be partly explained based on its affinity for plasma membrane GABA transporters.

Authors and Affiliations

Kinga Sałat, Anna Więckowska, Krzysztof Więckowski, Georg C Höfner, Jacek Kamiński, Klaus Wanner, Barbara Malawska, Katarzyna Kulig

Keywords

Related Articles

Antinociceptive effect of lidocaine in rats.

Lidocaine, a local anesthetic drug, exerts its effect by blocking sodium channels in peripheral sensory neurons. It is commonly used in clinical practice as a local anesthetic drug. This study was undertaken in order to...

Biotechnology and genetic engineering in the new drug development. Part II. Monoclonal antibodies, modern vaccines and gene therapy.

Monoclonal antibodies, modern vaccines and gene therapy have become a major field in modern biotechnology, especially in the area of human health and fascinating developments achieved in the past decades are impressive e...

Radiofrequency denervation with or without addition of pentoxifylline or methylprednisolone for chronic lumbar zygapophysial joint pain.

Radiofrequency neurolysis of lumbar medial branch is currently the only proven way to treat patients with chronic lumbar zygapophysial joint pain, however, in some patients it can cause transient postoperative pain due t...

Role of polymorphonuclear leukocyte infiltration in the mechanism of anti-inflammatory effect of amiodarone.

In many physiological bodily functions, and in the pathogenesis of inflammation, ions are exchanged between intracellular and extracellular areas. Amiodarone is a multiple ion channel (Ca(++), Na(+), K(+)) blocking drug,...

Luminal melatonin stimulates pancreatic enzyme secretion via activation of serotonin-dependent nerves.

Background: Serotonin (5-HT) is released from enterochromaffin cells in the gastrointestinal tract. 5-HT, via the activation of 5-HT2 and 5-HT3 receptors on vagal fibers, mediates pancreatic secretion through the mechani...

Download PDF file
  • EP ID EP161298
  • DOI -
  • Views 118
  • Downloads 0

How To Cite

Kinga Sałat, Anna Więckowska, Krzysztof Więckowski, Georg C Höfner, Jacek Kamiński, Klaus Wanner, Barbara Malawska, Katarzyna Kulig (2012). Synthesis and pharmacological properties of new GABA uptake inhibitors.. Pharmacological Reports, 64(4), 817-833. https://europub.co.uk/articles/-A-161298